Related Experiment Video
Updated: Mar 29, 2026

05:35
Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
Published on: January 19, 2024
1.7K
[ Preventing adverse drug events using clinical decision support systems]
Ali Reza Salili1,2, Felix Hammann2, Anne B Taegtmeyer2
11 Medizinische Universitätsklinik, Kantonsspital Aarau.
Therapeutische Umschau. Revue Therapeutique
|December 15, 2015
Summary
Adverse drug events are a significant patient risk. Computerized systems like CPOE and CDSS aim to reduce errors, but their proven patient benefits require further study.
Area of Science:
- Clinical Informatics
- Patient Safety
- Health Information Technology
Context:
- Adverse drug events (ADEs) present substantial clinical risks and consequences.
- Computerized Physician Order Entry (CPOE) and Clinical Decision Support Systems (CDSS) are widely adopted to mitigate these risks.
Purpose:
- To evaluate the current status, risks, benefits, and future potential of CPOE/CDSS in reducing prescribing errors and drug interactions.
- To assess the quantifiable impact of these systems on patient outcomes.
Summary:
- CPOE and CDSS are increasingly used to enhance medication safety by preventing errors and identifying harmful drug interactions.
- Despite their popularity, definitive evidence of the quantifiable benefits of CPOE/CDSS for patients remains limited.
- This review examines the present landscape, challenges, and future directions for these critical health IT systems.
Impact:
- Highlights the need for rigorous evaluation of CPOE/CDSS effectiveness in improving patient safety.
- Informs healthcare providers and policymakers on the current capabilities and limitations of medication safety technologies.
- Guides future development and implementation strategies for health IT to maximize patient benefit.
Related Concept Videos
Nursing Clinical Information System
1.4K
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
1.4K
Pharmacovigilance
1.9K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K
Therapeutic Drug Monitoring: Affecting Factors
332
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
332
Pharmaceutical Poisoning: Potential Scenarios
77
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
77
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
71
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
71
Structure-Activity Relationships and Drug Design
2.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
2.0K
